Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Unfortunately I have to whole heartedly agree with ya man. Time has begun catching up with Dr. Odidi the scientist and his innate ability to screw everything up.

I really thought we had a potential life changer brewing here 5 years ago but I clearly placed far far too much value in Dr. Odidi's science and overlooked the fact that he had zero experience running a public company.

I still firmly believe that he's a brilliant scientist but I'm done pretending that his performance over the past 3 and a half years deserves a passing grade.

And since time has proven that IPCI's generics pipeline has become an unmitigated disaster completely bereft of the potential everyone thought it would be delivering by now...sadly that appears to now have affected Dr. Odidi's vision/plans for unlocking the value in Rexista, Regabatin, PODRAS or the other 20 opioid based NDA's said to be in the pipeline.

We saw crystal clear evidence at the recent Rexista AdCom that it's incumbent on these bio companies to be adequately prepared for the adcom panel despite whatever guidance they're receiving from the FDA...so if much of the never ending generics pipeline delay is in fact IPCI's fault we can kiss away any of the expected potential we once had in the science behind their supposedly planned narcotics NDA's.

Dr. Odidi may as well just call Purdue and tell them he wants to go work for them at this point...it would be better than him continuing to fumble his way along as he has over the past 3.5 years destroying shareholder value because he can't deliver any relevant catalysts.

The problem is that Purdue views IPCI as zero threat whatsoever now and any other potential partnership suitors view IPCI at the weakest point in the company's history too.

So my own belief is that there are no savior partnership offers out there to be had as Dr. Odidi failed miserably at securing relevant partnerships early on when the opportunity existed.

Even if Pristiq and Lamictal get FDA approved and fully commercialized by MNK along with PAR launching the remaining 2 FocalinXR strengths and MNK increasing SeroquelXR sales all next year to the point that IPCI attains positive net income in the back half of 2018...my real fear is that Dr. Odidi is gonna sink millions more into Rexista and the ongoing Purdue litigation only to screw up the next Rexista AdCom and/or PDUFA date and get rejected again through oversights he's not adequately prepared for.

The last AdCom was chock full of never ending bs surrounding the blue dye. Everything from weezuhl's silly blue smurf presentation to the panel member that foolishly believed people would snort Rexista just so they could supposedly have cool badges of honor with blue dye smeared all over their faces.

So even with the additional studies on nasal and oral completed...there's nothing to say that the next adcom that comes won't be the same exact unmitigated disaster as the last one.

There of course is real potential here...but the real question in play is who amongst us is really prepared to endure what could be at least 18 more months of never ending bs b4 we even find out if Rexista ever becomes partnered with anyone!

Without Rexista or Regabatin partnerships there's nothing sexy enough in their generics pipeline to do anything but maybe get the share price north of $3 again in my humble opinion.